Literature DB >> 24621681

Minimum clinically important difference for the COPD Assessment Test: a prospective analysis.

Samantha S C Kon1, Jane L Canavan2, Sarah E Jones2, Claire M Nolan3, Amy L Clark4, Mandy J Dickson5, Brigitte M Haselden5, Michael I Polkey2, William D-C Man3.   

Abstract

BACKGROUND: The COPD Assessment Test (CAT) is responsive to change in patients with chronic obstructive pulmonary disease (COPD). However, the minimum clinically important difference (MCID) has not been established. We aimed to identify the MCID for the CAT using anchor-based and distribution-based methods.
METHODS: We did three studies at two centres in London (UK) between April 1, 2010, and Dec 31, 2012. Study 1 assessed CAT score before and after 8 weeks of outpatient pulmonary rehabilitation in patients with COPD who were able to walk 5 m, and had no contraindication to exercise. Study 2 assessed change in CAT score at discharge and after 3 months in patients admitted to hospital for more than 24 h for acute exacerbation of COPD. Study 3 assessed change in CAT score at baseline and at 12 months in stable outpatients with COPD. We focused on identifying the minimum clinically important improvement in CAT score. The St George's Respiratory Questionnaire (SGRQ) and Chronic Respiratory Questionnaire (CRQ) were measured concurrently as anchors. We used receiver operating characteristic curves, linear regression, and distribution-based methods (half SD, SE of measurement) to estimate the MCID for the CAT; we included only patients with paired CAT scores in the analysis.
FINDINGS: In Study 1, 565 of 675 (84%) patients had paired CAT scores. The mean change in CAT score with pulmonary rehabilitation was -2·5 (95% CI -3·0 to -1·9), which correlated significantly with change in SGRQ score (r=0·32; p<0·0001) and CRQ score (r=-0·46; p<0·0001). In Study 2, of 200 patients recruited, 147 (74%) had paired CAT scores. Mean change in CAT score from hospital discharge to 3 months after discharge was -3·0 (95% CI -4·4 to -1·6), which correlated with change in SGRQ score (r=0·47; p<0·0001). In Study 3, of 200 patients recruited, 164 (82%) had paired CAT scores. Although no significant change in CAT score was identified after 12 months (mean 0·6, 95% CI -0·4 to 1·5), change in CAT score correlated significantly with change in SGRQ score (r=0·36; p<0·0001). Linear regression estimated the minimum clinically important improvement for the CAT to range between -1·2 and -2·8 with receiver operating characteristic curves consistently identifying -2 as the MCID. Distribution-based estimates for the MCID ranged from -3·3 to -3·8.
INTERPRETATION: The most reliable estimate of the minimum important difference of the CAT is 2 points. This estimate could be useful in the clinical interpretation of CAT data, particularly in response to intervention studies. FUNDING: Medical Research Council and UK National Institute of Health Research.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24621681     DOI: 10.1016/S2213-2600(14)70001-3

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  208 in total

1.  Emergency Hospital Care for Exacerbation of COPD: Is Inhaled Maintenance Therapy Modified?

Authors:  Xavier Pomares; Concepción Montón; Marisa Baré; Marina Pont; Cristina Estirado; Joaquim Gea; José Maria Quintana; Silvia Vidal; Ana Santiago
Journal:  COPD       Date:  2015-09-29       Impact factor: 2.409

2.  Safety and Dose Study of Targeted Lung Denervation in Moderate/Severe COPD Patients.

Authors:  Arschang Valipour; Pallav L Shah; Christophe Pison; Vincent Ninane; Wim Janssens; Thierry Perez; Romain Kessler; Gaetan Deslee; Justin Garner; Christine Abele; Jorine E Hartman; Dirk-Jan Slebos
Journal:  Respiration       Date:  2019-06-20       Impact factor: 3.580

3.  Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study.

Authors:  Robert A Wise; Kenneth R Chapman; Benjamin M Scirica; David A Schoenfeld; Deepak L Bhatt; Sami Z Daoud; Beatriz Seoane; Colin Reisner; Esther Garcia Gil
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-24

4.  Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease.

Authors:  Laura M Paulin; Gregory B Diette; Paul D Blanc; Nirupama Putcha; Mark D Eisner; Richard E Kanner; Andrew J Belli; Stephanie Christenson; Donald P Tashkin; MeiLan Han; R Graham Barr; Nadia N Hansel
Journal:  Am J Respir Crit Care Med       Date:  2015-03-01       Impact factor: 21.405

5.  The London Chest Activity of Daily Living scale cut-off point to discriminate functional status in patients with chronic obstructive pulmonary disease.

Authors:  Aline Almeida Gulart; Anelise Bauer Munari; Suelen Roberta Klein; Raysa Silva Venâncio; Hellen Fontão Alexandre; Anamaria Fleig Mayer
Journal:  Braz J Phys Ther       Date:  2019-03-26       Impact factor: 3.377

6.  Psychometric Properties of the COPD-Specific Beliefs About Medicine Questionnaire in an Outpatient Population: A Rasch-Analysis.

Authors:  Marie Topp; Jørgen Vestbo; Erik Lykke Mortensen
Journal:  Chronic Obstr Pulm Dis       Date:  2016-09-02

7.  The Epworth Sleepiness Scale: Minimum Clinically Important Difference in Obstructive Sleep Apnea.

Authors:  Suhani Patel; Samantha S C Kon; Claire M Nolan; Ruth E Barker; Anita K Simonds; Mary J Morrell; William D-C Man
Journal:  Am J Respir Crit Care Med       Date:  2018-04-01       Impact factor: 21.405

8.  The Minimum Clinically Important Difference of the Incremental Shuttle Walk Test in Bronchiectasis: A Prospective Cohort Study.

Authors:  Jessica A Walsh; Suhani Patel; Ruth E Barker; Sarah E Jones; Stephanie C Wynne; Samantha S C Kon; Julius Cairn; Michael R Loebinger; Robert Wilson; William D-C Man; Claire M Nolan
Journal:  Ann Am Thorac Soc       Date:  2020-03

9.  Metoprolol for the Prevention of Acute Exacerbations of COPD.

Authors:  Mark T Dransfield; Helen Voelker; Surya P Bhatt; Keith Brenner; Richard Casaburi; Carolyn E Come; J Allen D Cooper; Gerard J Criner; Jeffrey L Curtis; MeiLan K Han; Umur Hatipoğlu; Erika S Helgeson; Vipul V Jain; Ravi Kalhan; David Kaminsky; Robert Kaner; Ken M Kunisaki; Allison A Lambert; Matthew R Lammi; Sarah Lindberg; Barry J Make; Fernando J Martinez; Charlene McEvoy; Ralph J Panos; Robert M Reed; Paul D Scanlon; Frank C Sciurba; Anthony Smith; Peruvemba S Sriram; William W Stringer; Jeremy A Weingarten; J Michael Wells; Elizabeth Westfall; Stephen C Lazarus; John E Connett
Journal:  N Engl J Med       Date:  2019-10-20       Impact factor: 91.245

10.  Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD.

Authors:  Patrícia Rebelo; Ana Oliveira; Cátia Paixão; Carla Valente; Lília Andrade; Alda Marques
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.